Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To demonstrate an improvement in progression free survival (PFS) with ZACTIMA™ (ZD6474) 300 mg as compared to Placebo in subjects with advanced or metastatic papillary or follicular Thyroid Carcinoma failing or unsuitable for Radioiodine therapy
Inclusion criteria
- Carcinoma papilar o folicular de tiroides localmente avanzado o metastásico,Advanced or metastatic papillary or follicular Thyroid Carcinoma